Logo

Dana-Farber

SpringWorks Therapeutics Licenses EGFR Inhibitors From Dana-Farber, Inks Two R&D Partnerships

The firm has entered collaborations with both Stanford Medicine and Ab Magnitude to further develop the new portfolio of lung cancer therapeutics.

MIT Spinoff Travera Looks to Validate Cell Mass as Broadly Predictive Cancer Biomarker
Premium

A recent study showed that the firm's technology could predict glioblastoma patients' chemo responses as well or better than an established genomic biomarker.

Broad Institute, Dana-Farber Open Enrollment in Cancer Research Project to All US, Canadian Patients

Any cancer patient can remotely partake in the Count Me In research initiative and share samples for molecular analysis and medical data to advance cancer research.

In Brief This Week: Syndax, Transgene, Sermonix, AccessHope, Achilles, Foundation Medicine

News items for the week of June 28, 2021.

Researchers Make Progress in Characterizing Diverse Mechanisms of KRAS Inhibitor Resistance
Premium

In a new study, Dana-Farber researchers and collaborators explain the myriad molecular reasons why KRAS-mutated cancers develop resistance to targeted therapy.

May 12, 2021

Dana-Farber Cancer Institute Receives $50M Gift to Advance Pancreatic Cancer Research

Mar 3, 2021

Nonprofit Count Me In to Return Genomic Results to Patients With Rare Cancers
Premium

Feb 19, 2021

In Brief This Week: AstraZeneca, Merck, Amgen, Kintara Therapeutics, Dana Farber Cancer Institute

Jan 22, 2021

MMRF, Dana Farber Amassing Data to Develop Smoldering Multiple Myeloma Monitoring Test
Premium

Dec 3, 2020

MMRF, Dana Farber Partner on Search for Biomarkers Linked to Smoldering Multiple Myeloma Progression

Aug 10, 2020

T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma

Aug 4, 2020

BostonGene Partners With Dana-Farber's Weinstock Lab on T-Cell Lymphoma Biomarker Research

Jul 24, 2020

MMRF Programs Aim to Boost Precision Med Knowledge, Access in Multiple Myeloma
Premium

Jun 26, 2020

Dana-Farber Team Reports Progress With Precision Oncology Trial Matching Software

Jun 4, 2020

Studies Show Potential of Video, Online Education to Expand Cancer Risk Genetic Test Access
Premium

Jun 3, 2020

BFOR Study Uses Digital Tools to Facilitate Population BRCA Screening in Ashkenazi Jewish Community

Jun 1, 2020

MET Tyrosine Kinase Inhibitor Shows 'Encouraging' Efficacy in Phase III Kidney Cancer Trial

May 1, 2020

NCI-MATCH Data Points to Possible Role for Mutated NRAS Codon in MEK Inhibitor Response

Apr 22, 2020

Pancreatic Cancer Clinical Risk Prediction Appears to Improve With Genetic, Biomarker Data

Apr 15, 2020

Glioma Hypermutation May Not Correspond to Checkpoint Immunotherapy Response, Study Suggests

Apr 8, 2020

Esophageal Cancer Case Study Suggests Utility as Clinicians Explore Expanded Uses for Liquid Biopsy
Premium

Mar 23, 2020

Lung Cancer Brain Metastasis Genomes Marked by Recurrent Amplifications, Deletions

Mar 19, 2020

Ovarian Cancer Mutational Signatures, Immune Features Tied to Combination Treatment Response

Feb 12, 2020

Angiosarcoma Research, Drug Trials Get Boost From Grassroots Effort Collecting Samples From Patients
Premium

Oct 8, 2019

ESMO Trial Results Raise Possibility of Neoadjuvant Keytruda Use in Triple-Negative Breast Cancer
Premium